Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Accumulated Expenses (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Accumulated Expenses data on record, last reported at $4.2 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 43.41% year-over-year to $4.2 million; the TTM value through Dec 2025 reached $4.2 million, down 43.41%, while the annual FY2025 figure was $4.2 million, 43.41% down from the prior year.
  • Accumulated Expenses reached $4.2 million in Q4 2025 per QTTB's latest filing, up from $3.9 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $19.8 million in Q1 2024 and bottomed at $2.4 million in Q1 2022.
  • Average Accumulated Expenses over 5 years is $8.2 million, with a median of $6.1 million recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: skyrocketed 687.64% in 2024, then tumbled 73.44% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $11.4 million in 2021, then skyrocketed by 64.08% to $18.7 million in 2022, then plummeted by 47.83% to $9.8 million in 2023, then dropped by 23.39% to $7.5 million in 2024, then tumbled by 43.41% to $4.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $4.2 million in Q4 2025, $3.9 million in Q3 2025, and $4.4 million in Q2 2025.